PHARMAORIGIN ApS: Financial statements 2022
CVR: 29178291
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
PHARMAORIGIN ApS (CVR 29178291) has filed annual accounts for 2022. In 2022, the company reported a net result of DKK 47,000 compared with DKK 40,000 the year before. Equity in the 2022 report amounted to DKK 1,196,000. The solvency ratio was 99.2%.
- Profit/Loss
- DKK 47,000
- Equity
- DKK 1,196,000
- Total Assets
- DKK 1,206,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | - | 47 t. | 1.2 mio. | - |
| 2021 | - | - | 40 t. | 1.1 mio. | - |
| 2020 | - | - | 13 t. | 1.1 mio. | - |
| 2019 | - | - | 18 t. | 1.1 mio. | 0 |
| 2018 | - | - | -23 t. | 1.1 mio. | - |
Keep an eye on PHARMAORIGIN ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
PHARMAORIGIN ApS has published its annual report for 2021. The net result was DKK 40,000.
About PHARMAORIGIN ApS
PHARMAORIGIN ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2005. The company is registered under the industry Drift af sundhedsvæsen i øvrigt i.a.n.. The company was previously named ApS KBUS 17 NR. 4503. The management consists of Danielle Marie Brown. The company is owned by Savara ApS. The company has 0 employees (2008). In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 100,000 compared with DKK 94,000 the year before. Equity in the 2025 report amounted to DKK 1,477,000.